课题基金 / 基金详情

DAUNORUBICIN DPSH GENE ON CYCLIZATION PATTERN FOR TYPE II POLYKETIDE SYNTHASE

DAUNORUBICIN DPSH GENE ON CYCLIZATION PATTERN FOR TYPE II POLYKETIDE SYNTHASE
II 型聚酮合酶环化模式中的柔红霉素 DPSH 基因
批准号:
6309123
负责人:
CHARLES R HUTCHINSON
金额:
$0.75万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-15 至 2005-02-28

项目摘要

项目成果

CHARLES R HUTCHINSON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Production of aklanoic acid, an early intermediate of daunorubicin (dnr) biosynthesis in Streptomyces peucetius, by hybrid type II polyletide synthase (PKS) genes was studied as a function of the order and type of genes cloned in a plasmid vector and expressed from the ermE* promoter. Compared with expression of the daunorubicin polyketide synthase (dps) genes in the normal order from their native promoter, the dnrG monooxygenase, dpsA and dpsB ketoreductase and dpsF cyclase genes, when cloned in this order in Streptomyces lividans, produced aklanoic acid and SEK-43. The latter compound is made from acetyl-coenzyme A instead of propionyl-coenzyme A as the starter unit and does not have the characteristic fused ring aromatic system of aklanoic acid. Replacement of either dpsG with its tcmM homolog or dnrG with the Streptomyces glaucescens tcmJ PKS gene resulted in little or no aklanoic acid production. In contrast, addition of the dpsH gene to the tcmJ, dpsA, dpsB, tcmM, dpsE and dpsF gene cassette restored cyclization pattern of aklanoic acid. The reason for the ability of dpsH to override the negative effect of tcmM and restore both the proper choice of starter unit and cyclization pattern is unknown, but overall results indicate that iterative type II PKSs can function aberrantly, perhaps as a function of abnormal protein stoichiometries or interactions. Currently, we are investigating structures of compounds when these gene cassettes are expressed in other mutants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leptomycin B Development for Cancer Therapy
  • 批准号:
    6788646
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2004
  • 负责人:
    CHARLES R HUTCHINSON
  • 依托单位:
Novel Geldanamycin Analogs as Anti-Tumor Agents
  • 批准号:
    6738936
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2004
  • 负责人:
    CHARLES R HUTCHINSON
  • 依托单位:
Laulimalide Production Genes
  • 批准号:
    6584382
  • 项目类别:
  • 资助金额:
    $16.26万
  • 财政年份:
    2003
  • 负责人:
    CHARLES R HUTCHINSON
  • 依托单位:
Novel Geldanamycin Analogs as Anti-tumor Agents
  • 批准号:
    6484983
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2002
  • 负责人:
    CHARLES R HUTCHINSON
  • 依托单位: